Cargando…

The Azaindole Framework in the Design of Kinase Inhibitors

This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Mérour, Jean-Yves, Buron, Frédéric, Plé, Karen, Bonnet, Pascal, Routier, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271083/
https://www.ncbi.nlm.nih.gov/pubmed/25460315
http://dx.doi.org/10.3390/molecules191219935
_version_ 1783376846832795648
author Mérour, Jean-Yves
Buron, Frédéric
Plé, Karen
Bonnet, Pascal
Routier, Sylvain
author_facet Mérour, Jean-Yves
Buron, Frédéric
Plé, Karen
Bonnet, Pascal
Routier, Sylvain
author_sort Mérour, Jean-Yves
collection PubMed
description This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Drug Discovery (FBDD) programs are presented. The various synthetic routes used to access these compounds and the chemical pathways leading to their synthesis are also discussed. An analysis of their mode of binding based on X-ray crystallography data gives structural insights for the design of more potent and selective inhibitors.
format Online
Article
Text
id pubmed-6271083
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62710832018-12-28 The Azaindole Framework in the Design of Kinase Inhibitors Mérour, Jean-Yves Buron, Frédéric Plé, Karen Bonnet, Pascal Routier, Sylvain Molecules Review This review article illustrates the growing use of azaindole derivatives as kinase inhibitors and their contribution to drug discovery and innovation. The different protein kinases which have served as targets and the known molecules which have emerged from medicinal chemistry and Fragment-Based Drug Discovery (FBDD) programs are presented. The various synthetic routes used to access these compounds and the chemical pathways leading to their synthesis are also discussed. An analysis of their mode of binding based on X-ray crystallography data gives structural insights for the design of more potent and selective inhibitors. MDPI 2014-11-28 /pmc/articles/PMC6271083/ /pubmed/25460315 http://dx.doi.org/10.3390/molecules191219935 Text en © 2014 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mérour, Jean-Yves
Buron, Frédéric
Plé, Karen
Bonnet, Pascal
Routier, Sylvain
The Azaindole Framework in the Design of Kinase Inhibitors
title The Azaindole Framework in the Design of Kinase Inhibitors
title_full The Azaindole Framework in the Design of Kinase Inhibitors
title_fullStr The Azaindole Framework in the Design of Kinase Inhibitors
title_full_unstemmed The Azaindole Framework in the Design of Kinase Inhibitors
title_short The Azaindole Framework in the Design of Kinase Inhibitors
title_sort azaindole framework in the design of kinase inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271083/
https://www.ncbi.nlm.nih.gov/pubmed/25460315
http://dx.doi.org/10.3390/molecules191219935
work_keys_str_mv AT merourjeanyves theazaindoleframeworkinthedesignofkinaseinhibitors
AT buronfrederic theazaindoleframeworkinthedesignofkinaseinhibitors
AT plekaren theazaindoleframeworkinthedesignofkinaseinhibitors
AT bonnetpascal theazaindoleframeworkinthedesignofkinaseinhibitors
AT routiersylvain theazaindoleframeworkinthedesignofkinaseinhibitors
AT merourjeanyves azaindoleframeworkinthedesignofkinaseinhibitors
AT buronfrederic azaindoleframeworkinthedesignofkinaseinhibitors
AT plekaren azaindoleframeworkinthedesignofkinaseinhibitors
AT bonnetpascal azaindoleframeworkinthedesignofkinaseinhibitors
AT routiersylvain azaindoleframeworkinthedesignofkinaseinhibitors